Serum Detect Launches with Novel T-Cell Analysis Approach for Cancer Early Detection at AACR
Serum Detect Inc.The new company, led by a former executive from Foundation Medicine and Gritstone bio, is using advances in T-cell receptor repertoire analysis to reveal previously undetectable signals in standard liquid biopsy samples.